# Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

> **NCT04612582** · PHASE4 · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Immunoglobulin Light-Chain Amyloidosis

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT04612582
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612582, "Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04612582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*